GLOBAL PRICING POLICIES AND COST-EFFECTIVENESS OF TRASTUZUMAB IN LATIN AMERICA

GLOBAL PRICING POLICIES AND COST-EFFECTIVENESS OF TRASTUZUMAB IN LATIN AMERICA

Pinchon-Riviere and colleagues have made an extremely timely contribution that addresses the thorny issues of innovative, high-cost medicines, global health disparities, and the growing interest and application of HTA in low- and middle-income countries.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of technology assessment in health care 2015-01, Vol.31 (1-2), p.1-1
1. Verfasser: Giffin, Robert B.
Format: Artikel
Sprache:eng
Schlagworte:
Cost analysis
Cost-Benefit Analysis
Developing countries
Economic models
Editorial
GDP
Gross Domestic Product
Health Policy
High income
Humans
Industrialized nations
Latin America
LDCs
Low income groups
Per capita
Pharmaceuticals
Trastuzumab
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Pinchon-Riviere and colleagues have made an extremely timely contribution that addresses the thorny issues of innovative, high-cost medicines, global health disparities, and the growing interest and application of HTA in low- and middle-income countries.
ISSN:0266-4623
1471-6348
DOI:10.1017/S026646231500029X